We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$19.6B
AUM Growth
-$1.06B
Cap. Flow
-$252M
Cap. Flow %
-1.29%
Top 10 Hldgs %
27.73%
Holding
2,867
New
60
Increased
922
Reduced
1,499
Closed
102

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$32.2M
2
NVDA icon
NVIDIA
NVDA
+$28.8M
3
SNV
Synovus
SNV
+$21M
4
AUB icon
Atlantic Union Bankshares
AUB
+$20.5M
5
MSFT icon
Microsoft
MSFT
+$20M

Sector Composition

Rank Sector Weight
1 Technology 28.46%
2 Financials 12.71%
3 Industrials 10.47%
4 Healthcare 10.16%
5 Consumer Discretionary 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAGN
2301
Magnera Corp
MAGN
$498M
$173K ﹤0.01%
18,230
+1,819
+11% +$23.3K
DCTH icon
2302
Delcath Systems
DCTH
$399M
$173K ﹤0.01%
18,669
GCO icon
2303
Genesco
GCO
$432M
$172K ﹤0.01%
5,927
+829
+16% +$23.8K
INR
2304
Infinity Natural Resources
INR
$234M
$172K ﹤0.01%
9,755
+1,767
+22% +$28.8K
RNG icon
2305
RingCentral
RNG
$4.77B
$172K ﹤0.01%
4,615
-555
-11% -$17.9K
SFIX
2306
Stitch Fix
SFIX
$563M
$171K ﹤0.01%
51,667
+112
+0.2% +$457
TSBK icon
2307
Timberland Bancorp
TSBK
$348M
$171K ﹤0.01%
4,333
-164
-4% -$6.24K
IBEX icon
2308
IBEX
IBEX
$480M
$169K ﹤0.01%
6,305
CLDT
2309
Chatham Lodging
CLDT
$638M
$169K ﹤0.01%
21,470
-6,123
-22% -$45.6K
BLFY
2310
DELISTED
Blue Foundry Bancorp
BLFY
$169K ﹤0.01%
12,749
KRT icon
2311
Karat Packaging
KRT
$832M
$169K ﹤0.01%
6,041
+1,190
+25% +$30K
RGNX icon
2312
Regenxbio
RGNX
$615M
$168K ﹤0.01%
20,030
-6,210
-24% -$65.2K
PACB icon
2313
Pacific Biosciences
PACB
$432M
$168K ﹤0.01%
127,090
+10,902
+9% +$19.5K
IHRT icon
2314
iHeartMedia
IHRT
$537M
$168K ﹤0.01%
57,439
+24
+0% +$79
OPTU
2315
Optimum Communications Inc
OPTU
$298M
$167K ﹤0.01%
128,468
+24,166
+23% +$38K
AURA icon
2316
Aura Biosciences
AURA
$729M
$167K ﹤0.01%
24,962
-69
-0.3% -$396
RCKT icon
2317
Rocket Pharmaceuticals
RCKT
$343M
$167K ﹤0.01%
46,551
+13,071
+39% +$51.9K
HVT icon
2318
Haverty Furniture Companies
HVT
$421M
$166K ﹤0.01%
7,839
-260
-3% -$6.33K
LTBR icon
2319
Lightbridge
LTBR
$259M
$165K ﹤0.01%
15,489
BGS icon
2320
B&G Foods
BGS
$297M
$165K ﹤0.01%
34,299
-3,166
-8% -$15.3K
OSPN icon
2321
OneSpan
OSPN
$572M
$165K ﹤0.01%
15,624
-2,759
-15% -$31.3K
ACRS icon
2322
Aclaris Therapeutics
ACRS
$744M
$165K ﹤0.01%
43,870
+18,273
+71% +$61.7K
SHOE
2323
Shoe Station Group
SHOE
$431M
$164K ﹤0.01%
10,525
+1,167
+12% +$22.2K
ITIC
2324
Investors Title Co
ITIC
$549M
$164K ﹤0.01%
753
PKBK icon
2325
Parke Bancorp
PKBK
$400M
$164K ﹤0.01%
5,761

Similar funds

MetLife Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, MetLife Investment Management held 2,867 positions worth $19.6B, down 5.1% from $20.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

MetLife Investment Management's Q1 2026 filing shows 60 new, 922 increased, 1,499 reduced and 102 closed positions. Its largest new stake was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M. The largest sale was Apple, an estimated $32.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.

  • MetLife Investment Management's largest Q1 2026 buy was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $62.3M increase.
  • MetLife Investment Management's biggest Q1 2026 reduction was Apple, cutting an estimated $32.2M.
  • MetLife Investment Management fully exited Synovus in Q1 2026, selling an estimated $21M.
  • MetLife Investment Management's ten largest holdings make up 28% of its $19.6B portfolio in Q1 2026.
  • MetLife Investment Management opened 60 new positions and closed 102 in Q1 2026.
  • MetLife Investment Management's portfolio value fell 5.1% quarter-over-quarter to $19.6B.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.